Course information
About the course

As our understanding of the causes of mental illness has developed, a growing number of pharmacological and non-pharmacological interventions have shown potential as novel treatments. While some of these remain experimental, others are emerging into routine clinical practice in the UK and around the world.
Drawing on recent exciting research findings, many of these interventions shine a new light on the causes and pathologies associated with psychiatric illnesses and are paving the way towards the future of psychiatry. From psychedelics to gut microbiome, this two-day course will introduce clinicians to the major new interventions with strong or promising clinical evidence. Learners will become familiar with the sorts of treatments currently available through either clinical or research pathways and be able to recommend these to their patients where appropriate. Each session will be taught by well-known academic and clinical experts from the IoPPN/Maudsley who work at the frontier of mental health research including Prof Allan Young (KCL Chair of Mood Disorders) and Prof David Veale (director of the Maudsley national service for OCD and related disorders).
This course will cover topics such as psilocybin, ketamine, MDMA, cannabis, transcranial magnetic stimulation, triple chronotherapy, and gut microbiome.
An interview with Dr James Rucker:
Course presented by
Click on the speaker's profile to find out more
-
Professor Allan Young
Chair of Mood Disorders & Director of the Centre for Affective Disorders
King’s College London
Read more -
Dr James Rucker
Consultant Psychiatrist and Senior Clinical Lecturer
King's College London
Read more -
Dr Mario F Juruena
Clinical Senior Lecturer in Translational Psychiatry & Maudsley Advanced Treatment and ECT Service Consultant Lead - MATS
Kings College London & SLaM NHS Foundation Trust
Read more -
Dr Derek Tracy
Consultant Psychiatrist & Clinical Director
Oxleas NHS Foundation Trust
Read more -
Dr Rafael Euba
Repetitive transcranial magnetic stimulation
Oxleas NHS Foundation Trust
Read more

Learning Objectives
After taking this course participants will be able to:
- Describe a variety of emerging novel pharmacological and non-pharmacological treatments in psychiatry
- Identify scientific and clinical evidence base supporting the major emerging treatments in psychiatry
- Determine whether some novel treatments may be appropriate for their patients
- Signpost patients to service or research programs that provide novel treatments
Course Information
Target audience
Academic, Assistant psychologist, Clinical psychologist, Consultant – non-psychiatry any, Consultant – psychiatry, CT1-3 – non-psychiatry any, CT1-3 – psychiatry, FY1, FY2, FY3, GP, GPVTS, Medical student, Occupational therapist, Psychology student, RMN, ST4-7 – non-psychiatry any, ST4-7 – psychiatry